NOAGH chief executive Dawn Howard says: “There was much of interest in the Prime Minister’s Mansion House address, with relevance to the animal medicines sector.
“NOAH welcomes Theresa May’s confirmation that we should have a close relationship with the European Medicines Agency (EMA), with ongoing dialogue between regulators and the progressive proposal that the UK would become an EMA associate member. Animal medicines are equally subject to the stringent regulatory controls of their human counterparts, also regulated using the EMA, and it is vital for both the UK and EU that there is cooperation on animal medicines innovation, safety, regulation, access and supply.
“We also welcome the recognition of the excellent standards of welfare of the UK’s food producing animals, and the Prime Minister’s support for this into the future. NOAH members help ensure the health of UK’s food producing animals, a vital component of these excellent welfare standards.
“Key areas of concern have been recognised: our industry, like others, needs certainty, so we look forward to progress being made and seeing words transformed to action. We will continue to work closely with our members and stakeholders, to help ensure that we make Brexit as successful as we possibly can for the animal medicines industry,” she said.
Notes for editors
1. For further information contact Dawn Howard or Alison Glennon at NOAH on 020 8367 3131, email email@example.com or see www.noah.co.uk
2. NOAH represents the UK animal medicines industry: its aim is to promote the benefits of safe, effective, quality medicines for the health and welfare of all animals.More Articles by National Office of Animal Health (NOAH) ...